Drug Shortage Report for OLANZAPINE ODT
Report ID | 211151 |
Drug Identification Number | 02343665 |
Brand name | OLANZAPINE ODT |
Common or Proper name | Olanzapine ODT |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-11-06 |
Estimated end date | 2024-01-29 |
Actual end date | 2024-01-22 |
Shortage status | Resolved |
Updated date | 2024-01-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-01-31 | French | Compare |
v3 | 2024-01-31 | English | Compare |
v2 | 2023-11-22 | French | Compare |
v1 | 2023-11-22 | English | Compare |
Showing 1 to 4 of 4